Drug Guidance for Subsidy 02/01/2019 Nintedanib and pirfenidone for treating idiopathic pulmonary fibrosis NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing nintedanib or p... See all × 02/01/2019 Nintedanib and pirfenidone for treating idiopathic pulmonary fibrosis NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing nintedanib or pirfenidone on the Medication Assistance Fund (MAF) for treating idiopathic pulmonary fibrosis, because of limited clinical benefits and unacceptable cost-effectiveness compared with best supportive care at the prices proposed by the manufacturers.
Post Marketing Information DHCPL 11/12/2017 Ofev® (nintedanib) – Risk of severe liver injury in patients with idiopathic pulmonary fibrosis
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Capsule, Liquid Filled 100 mg National University Hospital Tan Tock Seng Hospital Woodlands Health Campus Capsule, Liquid Filled 150 mg Changi General Hospital National University Hospital Sengkang General Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus
ORAL Select a brand starting with the letter: O OFEV SOFT CAPSULES 100MG [SIN14921P] OFEV SOFT CAPSULES 150MG [SIN14922P]